Cargando…
Bone morphogenetic protein 10 as a predictor for recurrent atrial fibrillation after catheter ablation
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Atrial fibrillation (AF) recurrence after catheter ablation (CA) poses a major challenge. The novel atrial-specific biomarker, bone morphogenetic protein 10 (BMP10), might aid in the selection of appropriate patients for CA. PURPOS...
Autores principales: | Hennings, E, Aeschbacher, S, Coslovsky, M, Paladini, R E, Spies, F, Voellmin, G, Conen, D, Zuern, C S, Krisai, P, Badertscher, P, Sticherling, C, Osswald, S, Knecht, S, Kuehne, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206880/ http://dx.doi.org/10.1093/europace/euad122.082 |
Ejemplares similares
-
Pulsed-field ablation versus single catheter high-power short-duration radiofrequency ablation for atrial fibrillation: procedural characteristics, myocardial injury and midterm outcomes
por: Weidlich, S, et al.
Publicado: (2023) -
Unique topological classification of complex reentrant atrial tachycardias enables optimal ablation strategy
por: Vandersickel, N, et al.
Publicado: (2023) -
Safety and durability of PFA for pulmonary vein isolation: comparison to a reference RF data base
por: De Becker, B, et al.
Publicado: (2023) -
Detection of the most dominant drivers of atrial fibrillation based on repetitive activity in sequential electro-anatomical mapping
por: Hermans, B J M, et al.
Publicado: (2023) -
Implementation of CLOSE protocol for pulmonary vein isolation in paroxysmal atrial fibrillation by young electrophysiologists in real world clinical practice
por: Chatzikyriakou, S, et al.
Publicado: (2023)